NEJM Group

CardioExchange Archive

CardioExchange, an NEJM practice community for medical professionals dedicated to improving cardiac patient care, was active from 2009 to 2015. CardioExchange fostered discussion between clinicians from across the globe.

Posts Tagged ‘biolimus-eluting biodegradable-polymer-coated stent’

RSS

January 26th, 2015

Selections from Richard Lehman’s Literature Review: January 26th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include dietary sodium content, mortality, and CVD risk in older adults, the ROX CONTROL HTN study, and more.

Categories: General
Tags: acute myocardial infarction, biolimus-eluting biodegradable-polymer-coated stent, cardiovascular risk, central arteriovenous anastomosis, dietary sodium, Elecsys Troponin T high-sensitive assay, high-sensitivity cardiac troponin, mortality, myocardial infarction, older patients, uncontrolled hypertension, women, zotarolimus-eluting durable-polymer-coated stent


  • Search the Archive

  • Archives by Date

  • RSS NEJM — Recent Cardiology Articles

    • Managing Asymptomatic Carotid Stenosis January 15, 2026
      The management of carotid-artery stenosis that has not caused recent symptoms — asymptomatic carotid stenosis — has been controversial. Clinical trials that began more than 30 years ago showed a small benefit of carotid endarterectomy as compared with medical treatment, but improvements in medical prevention of stroke call into question...
    • Sudden Cardiac Arrest in Athletes January 15, 2026
      Sudden cardiac arrest in athletes may be attributable to cardiac and noncardiac causes. With diagnosis and treatment, a return to play may be reasonable. Prevention, emergency planning, and shared decision making are key.
    • Medical Management and Revascularization for Asymptomatic Carotid Stenosis January 15, 2026
      In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit.
    • Fish Oil for Patients Receiving Hemodialysis — Red Herring or Great Catch? January 8, 2026
      More than 470,000 patients with kidney failure receive hemodialysis in the United States alone, with worldwide estimates approaching 3 million patients. Mortality from kidney failure remains unacceptably high, with recent U.S. estimates of approximately 18% per year — higher than the mortality observed among patients with heart failure, diabetes, or...
    • VESALIUS and the Anatomy of High-Risk Prevention January 8, 2026
      In the 16th century, the Flemish physician and anatomist Andreas Vesalius fundamentally advanced our understanding of the structure and function of the human body, providing particular insight on the inner workings of the circulatory system.1 The results of the VESALIUS-CV (Effect of Evolocumab in Patients at High Cardiovascular...
  • Tag Cloud

    • ACS AF AHA anticoagulation aortic valve replacement apixaban aspirin atrial fibrillation CABG cardiovascular risk cholesterol clopidogrel dabigatran diabetes diet drug-eluting stents epidemiology ESC exercise FDA FDA approvals Fellowship training guidelines HDL heart failure hypertension ICDs MI myocardial infarction obesity PCI Primary PCI risk factors rivaroxaban statins STEMI stents stroke stroke prevention TAVI TAVR type 2 diabetes venous thromboembolism warfarin women
NEJM Group

Copyright © 2026 Massachusetts Medical Society. All rights reserved.

The content of this site is intended for health care professionals. Copyright | Terms | Privacy Policy |